| Have
you or a member of your family developed a serious medical
condition such as: |
|
Under Federal Law, the
manufacturer of a drug is required to revise its label to include a
warning as soon as there is reasonable evidence of an association of a
serious hazard with a drug.
The FDA has required Hoffmann-La Roche to change
their label for Accutane many times. The June 2002 Label states -
...bone and muscle damage - ...In a separate open-label extension
study of 10 patients... ...showed a decrease in mean lumbar spine bone
mineral density... ...Spontaneous reports of osteoporosis, osteopenia,
bone fractures, and delayed healing of bone fractures have been seen in
the Accutane population. While causality to Accutane has not been
established, an effect cannot be ruled out. Longer term effects have
not been studied...
Pursuant to FDA Rules and Regulation, the reporting
of Adverse Side Effects is on a voluntary basis. In other words, the
doctor, hospital, or other medical person or facility are not required
by law to report an adverse side effect from a drug. The FDA reported
that perhaps only one in one hundred side effects ever get reported.
One could only imagine about how many serious Adverse Side Effects
there are from taking Accutane, that have never been reported to anyone!
ARTICLES & INFORMATION
January 21, 1983 -
Accutane - Bone Swelling -
Five of seven patients taking Accutane for acne
showed symptoms and/or x-ray evidence of swelling of skeletal bones.
Frank Yoder, M.D., who has been closely associated with Accutane since
the first clinical study, feels that the potential toxicity of this
medication has been seriously underemphasized. (Journal of the
American Medical Association 294(3)350-351, January 21, 1983)
August 16, 1986 -
Accutane - Muscle Damage -
Accutane (isotretinoin) may cause muscle damage
according to a report from Israel. It has been estimated that 15
percent of patients given Accutane develop musculoskeletal symptoms
during treatment.
Two young males given Accutane for nodulocystic [sic]
acne developed weakness and muscle pain a few days after isotretinoin
therapy was begun. They had muscle tenderness to touch. After the
medication was discontinued the muscle pain gradually disappeared.
Vitamin A toxicity is known to produce muscle stiffness and pain.
(British Medical Journal 293:425-6, August 16, 1986)
November 6, 1986 -
Accutane - Tendon and Ligament Calcification -
Accutane (isotretinoin) given to treat acne, produced
calcifications of tendons and ligaments in 32 of 38 patients in a study
carried out at the National Institutes of Health. The ankles, pelvis
and knees were the most common sites of calcification. (New England
Journal of Medicine 315(19)1177-82, November 6, 1986)
May 10, 2002 -
New FDA Warning -
WARNING
The Food and Drug Administration (FDA) has approved
updated labeling for Accutane, warning of the risk of musculoskeletal
adverse events. Patients taking Accutane have reported spontaneous
osteoporosis, osteopenia, bone fractures, and delayed healing of bone
fractures. The new warning states that the link to Accutane has not
been established, but that care should be taken and the drug should be
used no longer than the recommended duration of therapy.
FDA - Accutane Information Page
|
If you believe you have been injured or have suffered a severe side effect from the use of Accutane, it may be that you are entitled to compensation.
It is important that if you contact our firm for a free case evaluation. Our lawyers will analyze your case and advise whether you are entitled to compensation. Call 1-800-404-9281 or email us here.
|
|
|
|
If you send an e-mail message to
the Robichaux Law Firm, it does not constitute
an attorney/client privilege or relationship and does not commit
the law firm to undertake any representation or obligation in
connection with responding to that e-mail. An attorney/client
relationship will not be created until the law firm considers
potential conflicts of interest and any necessary fee agreement
is entered into between the client and the law firm. A person
should be aware that the use of transmission of e-mail may not
be a secure transmission; therefore, any privileged or
confidential information should not be transmitted by e-mail.
The information you obtain at this site is not, nor is it
intended to be legal or medical advice. You should consult an attorney for individual advice regarding your own situation.
Accutane is a registered trademark of Roche Pharmaceuticals. This is not a Roche Pharmaceuticlas website nor is it authorized by Roche.
The material and statements in this website do not create, and are not intended to create, an attorney-client relationship, and no one in the firm Robichaux Law Firm is agreeing to represent you in any legal matter. If you are already represented by an attorney, then no attorney or employee of this firm can speak with you nor provide legal advice to you without the consent of your attorney. Accordingly, if you are already represented by an attorney, please do not contact one of our attorneys or employees without your lawyer's consent.
This web site does not offer, and is not intended to offer, legal or medical advice. The content on this web site is for informational and educational purposes only, and is not intended as a substitute for the professional judgment of a legal and/or healthcare professional, and you should not rely upon any material or statements in this web site for legal or medical purposes. We recommend that you review this information carefully with your doctor or healthcare professional before making any decisions regarding your health or recommended medical treatment. While reasonable attempts have been made to insure the accuracy of the information on this web site, our firm cannot make express or implied representations or warranties about the accuracy or completeness of the information.
Materials appearing at this web site may only be reproduced in their entirety (without modification) and must include the disclaimers.
The hiring of a lawyer is an important decision that should not be based solely upon advertisements. Before you decide, ask us to send you free written information about our qualifications and experience.
© 2008 AccutaneNews.com All rights reserved.
|